TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease.

Immunology 2013 May;139(1):19-29

Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

Bile acids (BAs) play important roles not only in lipid metabolism, but also in signal transduction. TGR5, a transmembrane receptor of BAs, is an immunomodulative factor, but its detailed mechanism remains unclear. Here, we aimed to delineate how BAs operate in immunological responses via the TGR5 pathway in human mononuclear cell lineages. We examined TGR5 expression in human peripheral blood monocytes, several types of in vitro differentiated macrophages (Mϕs) and dendritic cells. Mϕs differentiated with macrophage colony-stimulating factor and interferon-γ (Mγ-Mϕs), which are similar to the human intestinal lamina propria CD14(+) Mϕs that contribute to Crohn's disease (CD) pathogenesis by production of pro-inflammatory cytokines, highly expressed TGR5 compared with any other type of differentiated Mϕ and dendritic cells. We also showed that a TGR5 agonist and two types of BAs, deoxycholic acid and lithocholic acid, could inhibit tumour necrosis factor-α production in Mγ-Mϕs stimulated by commensal bacterial antigen or lipopolysaccharide. This inhibitory effect was mediated by the TGR5-cAMP pathway to induce phosphorylation of c-Fos that regulated nuclear factor-κB p65 activation. Next, we analysed TGR5 levels in lamina propria mononuclear cells (LPMCs) obtained from the intestinal mucosa of patients with CD. Compared with non-inflammatory bowel disease, inflamed CD LPMCs contained more TGR5 transcripts. Among LPMCs, isolated CD14(+) intestinal Mϕs from patients with CD expressed TGR5. In isolated intestinal CD14(+) Mϕs, a TGR5 agonist could inhibit tumour necrosis factor-α production. These results indicate that TGR5 signalling may have the potential to modulate immune responses in inflammatory bowel disease.

Download full-text PDF

Source
http://dx.doi.org/10.1111/imm.12045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634536PMC
May 2013
1619 Reads

Publication Analysis

Top Keywords

tgr5
11
crohn's disease
8
bowel disease
8
cd14+ mϕs
8
lamina propria
8
tgr5 agonist
8
inhibit tumour
8
dendritic cells
8
factor-α production
8
necrosis factor-α
8
tumour necrosis
8
vitro differentiated
8
expressed tgr5
8
pro-inflammatory cytokines
8
tgr5 signalling
8
production pro-inflammatory
8
intestinal
5
mϕs
5
lithocholic acid
4
acid inhibit
4

The Emergence of Digital Opinion Leaders + Blood Cancer DOL Dashboard

This month we’ve pulled together a dashboard of 20 of the most impactful Digital Opinion Leaders (DOLs) related to Blood Cancers. Please take a live look at the DOL Board for this group of experts.

Read Article

Similar Publications